Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Clasificación en acciones #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Precio por acción
$59.98
Última sincronización: 2024-12-13
Capitalización bursátil
$1.22B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Longboard Pharmaceuticals, Inc. (LBPH)

Categoría

Historial de desdoblamientos de acciones de Longboard Pharmaceuticals, Inc. (LBPH)
La acción Longboard Pharmaceuticals, Inc. (símbolo: LBPH) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 29, 2026.
Una acción LBPH comprada antes de Aug 29, 2026 equivaldría hoy a 0 acciones LBPH.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH